Literature DB >> 15846572

Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors.

Paul J Norman1, Peter Parham.   

Abstract

The killer cell immunoglobulin-like receptors (KIR) for human leukocyte antigen (HLA) modulate innate and adaptive immunity by controlling effector cells. HLA and KIR are encoded in genomic regions that have complex organization and exhibit exceptional diversity within and among human population groups. This diversity is likely to have arisen to combat a constantly evolving pathogen challenge. Numerous variations influence the expression level or function of KIR molecules and can affect their interaction with HLA, with important implications for the immune response. The functional variety of natural immune responses that are controlled by HLA and KIR interactions is genetically determined and maintained by natural selection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846572     DOI: 10.1053/j.seminhematol.2005.01.007

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  15 in total

1.  Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation.

Authors:  William H Carr; David B Rosen; Hisashi Arase; Douglas F Nixon; Jakob Michaelsson; Lewis L Lanier
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 2.  In celebration of Ruggero Ceppellini: HLA in transplantation.

Authors:  E W Petersdorf
Journal:  HLA       Date:  2017-02       Impact factor: 4.513

3.  Use of dried blood spots for the determination of genetic variation of interleukin-10, killer immunoglobulin-like receptor and HLA class I genes.

Authors:  B G Ndlovu; S Danaviah; E Moodley; M Ghebremichael; R Bland; J Viljoen; M-L Newell; T Ndung'u; W H Carr
Journal:  Tissue Antigens       Date:  2011-11-22

Review 4.  The extensive polymorphism of KIR genes.

Authors:  Derek Middleton; Faviel Gonzelez
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

5.  Practical Considerations and Workflow in Utilizing KIR Genotyping in Transplantation Medicine.

Authors:  Makoto Yawata; Nobuyo Yawata
Journal:  Methods Mol Biol       Date:  2022

6.  The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

Authors:  Li Ping Dou; De Hua Zheng; Chang Wang; Jun Hua Liu; Jing Fen Sun; Hai Jie Jin; Chun Ji Gao; Li Yu; Wan Ming Da
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

7.  Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.

Authors:  Olivier Morteau; Samkeliso Blundell; Aron Chakera; Sophia Bennett; Charita M Christou; Philip D Mason; Richard J Cornall; Christopher A O'Callaghan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors.

Authors:  John A Hammond; Lisbeth A Guethlein; Laurent Abi-Rached; Achim K Moesta; Peter Parham
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

9.  MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Mari Malkki; Theodore A Gooley; Stephen R Spellman; Michael D Haagenson; Mary M Horowitz; Tao Wang
Journal:  Sci Transl Med       Date:  2012-07-25       Impact factor: 17.956

10.  Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region.

Authors:  Huan Cao; Bernard de Bono; Katherine Belov; Emily S Wong; John Trowsdale; Alexander David Barrow
Journal:  Immunogenetics       Date:  2009-04-01       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.